UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Aortic dissection. Prevalence, cause, and results of late reoperations

The Journal of thoracic and cardiovascular surgery, 1994-08, Vol.108 (2), p.199-205; discussion 205-6

1994

Volltextzugriff (PDF)

Risk of replacement of descending aorta with a standardized left heart bypass technique

The Journal of thoracic and cardiovascular surgery, 1994-01, Vol.107 (1), p.126-133

1994

Volltextzugriff (PDF)

Risk of replacement of descending aorta with a standardized left heart bypass technique. Discussion

Journal of thoracic and cardiovascular surgery, 1994, Vol.107 (1), p.126-133

1994

Volltextzugriff (PDF)

Aortic dissection : prevalence, cause, and results of late reoperations. Discussion

Journal of thoracic and cardiovascular surgery, 1994, Vol.108 (2), p.199-206

1994

Volltextzugriff (PDF)

Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency

European journal of cancer (1990), 2017-11, Vol.86, p.266-274

2017

Volltextzugriff (PDF)

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

The New England journal of medicine, 2011-05, Vol.364 (19), p.1817-1825

2011

Volltextzugriff (PDF)

Preservation of aortic valve in type A aortic dissection complicated by aortic regurgitation. Discussion

Journal of thoracic and cardiovascular surgery, 1991, Vol.102 (1), p.62-75

1991

Volltextzugriff (PDF)

Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study

Annals of oncology, 2021-05, Vol.32 (5), p.600-608

2021

Volltextzugriff (PDF)

Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2012-10, Vol.23 Suppl 7, p.vii33-vii40

2012

Volltextzugriff (PDF)

New strategies and designs in pancreatic cancer research: consensus guidelines report from a European expert panel

Annals of oncology, 2012-03, Vol.23 (3), p.570-576

2012

Volltextzugriff (PDF)

FOLFIRINOX for Locally Advanced Pancreatic Adenocarcinoma: Results of an AGEO Multicenter Prospective Observational Cohort

Annals of surgical oncology, 2015-01, Vol.22 (1), p.295-301

2015

Volltextzugriff (PDF)

FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trial

European journal of cancer (1990), 2018-11, Vol.104, p.108-116

2018

Volltextzugriff (PDF)

Panitumumab combined with irinotecan for patients with KRAS wild-type metastatic colorectal cancer refractory to standard chemotherapy: a GERCOR efficacy, tolerance, and translational molecular study

Annals of oncology, 2013-02, Vol.24 (2), p.412-419

2013

Volltextzugriff (PDF)

Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict adjuvant chemosensitivity in pancreatic cancer

Translational oncology, 2022-02, Vol.16, p.101315-101315, Article 101315

2022

Volltextzugriff (PDF)

Clinical features and outcomes of patients with pancreatic cancer requiring unplanned medical ICU admission: A retrospective multicenter study

Digestive and liver disease, 2024-03, Vol.56 (3), p.514-521

2024

Volltextzugriff (PDF)

Conservative surgery vs. duodeneopancreatectomy in primary duodenal gastrointestinal stromal tumors (GIST): A retrospective review of 114 patients from the French Sarcoma Group (FSG)

European journal of surgical oncology, 2014-10, Vol.40 (10), p.1369-1375

2014

Volltextzugriff (PDF)

TTD and %TUDD: New SAS macro programs to calculate the survival data of the time to deterioration for patient-reported outcomes data in oncology

Computer methods and programs in biomedicine, 2022-02, Vol.214, p.106537-106537, Article 106537

2022

Volltextzugriff (PDF)

Development and validation of AI-assisted transcriptomic signatures to personalize adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma

Annals of oncology, 2024-09, Vol.35 (9), p.780-791

2024

Volltextzugriff (PDF)

Demystifying BRAF Mutation Status in Colorectal Liver Metastases : A Multi-institutional, Collaborative Approach to 6 Open Clinical Questions

Annals of surgery, 2023-09, Vol.278 (3), p.e540-e548

2023

Volltextzugriff (PDF)

Safety and efficacy of trifluridine/tipiracil (FTD/TPI) in metastatic colorectal cancer (mCRC) patients according to previous treatment with regorafenib in the international phase IIIb PRECONNECT study

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii155

2018

Volltextzugriff (PDF)

Thoracic Endovascular Aortic Repair (TEVAR) for the treatment of aortic diseases: a position statement from the European Association for Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

European journal of cardio-thoracic surgery, 2012-07, Vol.42 (1), p.17-24

2012

Volltextzugriff (PDF)

Causes, management, and prognosis of severe gastrointestinal bleedings in critically ill patients with pancreatic cancer: A retrospective multicenter study

Digestive and liver disease, 2024-09

2024

Volltextzugriff (PDF)

LBA62 Preoperative modified FOLFIRINOX (mFOLFIRINOX) with or without chemoradiation (CRT) in borderline resectable pancreatic cancer (BRPC): Results from the randomized phase II trial PANDAS/PRODIGE 44

Annals of oncology, 2024-09, Vol.35, p.S1252-S1252

2024

Volltextzugriff (PDF)

Surgical and Oncological Outcomes After Preoperative FOLFIRINOX Chemotherapy in Resected Pancreatic Cancer: An International Multicenter Cohort Study

Annals of surgical oncology, 2023-03, Vol.30 (3), p.1463-1473

2023

Volltextzugriff (PDF)

1 – 25 von 116

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(107)
Mit Volltextzugriff
(103)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(41)
Life Sciences & Biomedicine
(40)
Science & Technology
(40)
Biological And Medical Sciences
(27)
Medical Sciences
(26)
Female
(23)
Male
(21)
Surgery
(21)
Middle Aged
(20)
Aged
(19)
Cardiac & Cardiovascular Systems
(16)
Cardiovascular System & Cardiology
(16)
Oncology
(16)
Adult
(14)
Respiratory System
(14)
Life Sciences
(11)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(11)
Treatment Outcome
(10)
Cardiology. Vascular System
(9)
Surgery Of The Heart
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Aortic dissection. Prevalence, cause, and results of late reoperations

Risk of replacement of descending aorta with a standardized left heart bypass technique

Risk of replacement of descending aorta with a standardized left heart bypass technique. Discussion

Aortic dissection : prevalence, cause, and results of late reoperations. Discussion

Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Preservation of aortic valve in type A aortic dissection complicated by aortic regurgitation. Discussion

Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study

Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up

New strategies and designs in pancreatic cancer research: consensus guidelines report from a European expert panel

FOLFIRINOX for Locally Advanced Pancreatic Adenocarcinoma: Results of an AGEO Multicenter Prospective Observational Cohort

FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trial

Panitumumab combined with irinotecan for patients with KRAS wild-type metastatic colorectal cancer refractory to standard chemotherapy: a GERCOR efficacy, tolerance, and translational molecular study

Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict adjuvant chemosensitivity in pancreatic cancer

Clinical features and outcomes of patients with pancreatic cancer requiring unplanned medical ICU admission: A retrospective multicenter study

Conservative surgery vs. duodeneopancreatectomy in primary duodenal gastrointestinal stromal tumors (GIST): A retrospective review of 114 patients from the French Sarcoma Group (FSG)

TTD and %TUDD: New SAS macro programs to calculate the survival data of the time to deterioration for patient-reported outcomes data in oncology

Development and validation of AI-assisted transcriptomic signatures to personalize adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma

Demystifying BRAF Mutation Status in Colorectal Liver Metastases : A Multi-institutional, Collaborative Approach to 6 Open Clinical Questions

Safety and efficacy of trifluridine/tipiracil (FTD/TPI) in metastatic colorectal cancer (mCRC) patients according to previous treatment with regorafenib in the international phase IIIb PRECONNECT study

Causes, management, and prognosis of severe gastrointestinal bleedings in critically ill patients with pancreatic cancer: A retrospective multicenter study

LBA62 Preoperative modified FOLFIRINOX (mFOLFIRINOX) with or without chemoradiation (CRT) in borderline resectable pancreatic cancer (BRPC): Results from the randomized phase II trial PANDAS/PRODIGE 44

Surgical and Oncological Outcomes After Preoperative FOLFIRINOX Chemotherapy in Resected Pancreatic Cancer: An International Multicenter Cohort Study

Suchergebnisse filtern